Posts

Showing posts with the label market access
Show all
Image

Most-Favored-Nation Drug Pricing: Policy Shift or Pressure Tactic?

Image

EU HTA is now live: what do we do now?

Image

Changes in Market Access in Europe and Implications for Clinical Development Planning: Joint Clinical Assessments

Image

KISUNLA: Another breakthrough for Alzheimer’s Disease patients

Image

Fabhalta: aprendizajes para el desarrollo exitoso de fármacos en enfermedades raras

Image

Fabhalta: learnings for successful drug development in rare diseases